SKYSCRAPER-09: Phase II, randomised study of tiragolumab (tira) plus atezolizumab (atezo) and atezo plus placebo (pbo) as first-line (1L) treatment in patients (pts) with recurrent/ metastatic PD-L1+squamous cell carcinoma of the head and neck (R/M SCCHN)

Psyrri, A.; Le Tourneau, C.; Daste, A.; Dechaphunkul, A.; Hsieh, C-y.; Wong, D. J.; Lee, S-H.; Ngamphaiboon, N.; Fayette, J.; Johnson, M. L.; Gillison, M.; Bradley, D.; Hoang, T.; Stroud, C. R. G.; Matheny, C.; Alias, F.; Zhang, W.; Yan, Y.; Harrington, K. J.

doi:10.1016/j.annonc.2025.08.1963

상세 보기

SKYSCRAPER-09: Phase II, randomised study of tiragolumab (tira) plus atezolizumab (atezo) and atezo plus placebo (pbo) as first-line (1L) treatment in patients (pts) with recurrent/ metastatic PD-L1+squamous cell carcinoma of the head and neck (R/M SCCHN)

Psyrri, A.;
Le Tourneau, C.;
Daste, A.;
Dechaphunkul, A.;
Hsieh, C-y.;
... Lee, S-H.;
외 13명

Citations

WEB OF SCIENCE

0

Citations

SCOPUS

0

제목: SKYSCRAPER-09: Phase II, randomised study of tiragolumab (tira) plus atezolizumab (atezo) and atezo plus placebo (pbo) as first-line (1L) treatment in patients (pts) with recurrent/ metastatic PD-L1+squamous cell carcinoma of the head and neck (R/M SCCHN)

저자: Psyrri, A.; Le Tourneau, C.; Daste, A.; Dechaphunkul, A.; Hsieh, C-y.; Wong, D. J.; Lee, S-H.; Ngamphaiboon, N.; Fayette, J.; Johnson, M. L.; Gillison, M.; Bradley, D.; Hoang, T.; Stroud, C. R. G.; Matheny, C.; Alias, F.; Zhang, W.; Yan, Y.; Harrington, K. J.

DOI: 10.1016/j.annonc.2025.08.1963

발행일: 2025-09

유형: Meeting Abstract

저널명: Annals of Oncology

권: 36

ScholarWorks@성균관대학교

상세 보기